Crozer-Keystone Health System
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.crozer.org
Clinical Trials
3
Active:1
Completed:1
Trial Phases
3 Phases
Phase 2:1
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
Phase 2
Completed
- Conditions
- Metastatic Nonsmall Cell Lung CancerNon Small Cell Lung Cancer
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Crozer-Keystone Health System
- Target Recruit Count
- 3
- Registration Number
- NCT03825510
- Locations
- 🇺🇸
Philadelphia CyberKnife, Philadelphia, Pennsylvania, United States
CyberKnife Dose Escalation Prostate Cancer Trial
Not Applicable
Active, not recruiting
- Conditions
- Prostate NeoplasmProstate CancerProstate Adenocarcinoma
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Crozer-Keystone Health System
- Target Recruit Count
- 100
- Registration Number
- NCT03822494
- Locations
- 🇺🇸
Philadelphia CyberKnife, Philadelphia, Pennsylvania, United States
Reactor Thoracostomy
Phase 3
- Conditions
- PneumothoraxHemothorax
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2018-11-08
- Lead Sponsor
- Crozer-Keystone Health System
- Target Recruit Count
- 54
- Registration Number
- NCT03734471
News
No news found